Sign inJoin waitlistJoin the waitlist

Jennifer Guimbellot

Chief of Pulmonology and Sleep Medicine · University of Arkansas for Medical Sciences (UAMS) College of Medicine

Credentials: · · · · · · ·

History

Pulmonology and Sleep Medicine Division · University of Arkansas for Medical Sciences (UAMS) College of Medicine
Present
UAMS Health - Family Medical Center in Springdale
Present
Department Division · University of Arkansas for Medical Sciences (UAMS) College of Medicine
Present

Pediatric Pulmonology
University of North Carolina Hospitals
2012–2015
New York Presbyterian Hospital
2011–2012
Pediatrics
University of Arkansas for Medical Sciences (UAMS) College of Medicine
2008–2011
University of Alabama at Birmingham
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
2004–2008
Mississippi State University
2000–2004

Research

Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines
Journal of Biological Chemistry · 2004 · 111 citations
Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation
Journal of Cystic Fibrosis · 2021 · First of 9 authors · Corresponding · 59 citations
Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis
BMC Medical Genomics · 2009 · First of 7 authors · 59 citations

Steve Rowe
12 papers
Charles Esther
3 papers
ES
Eric Sorscher
3 papers
George Solomon
3 papers
Hector Gutierrez
3 papers
Kathleen Ramos
3 papers
Manu Jain
3 papers
Scott Sagel
3 papers
Bryan Garcia
2 papers
CL
Christoph Lehmann
2 papers
Christopher Goss
2 papers
DH
Daniel Horton
2 papers

Grants

Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy Study
National Institute of Child Health and Human Development · R01
Contact PI · $1.3M · Arkansas Children's Hospital Res Inst
2025–2030
ENsuring ACcess to Optimal Therapy in CF: ENACT Study
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.8M · Arkansas Children's Hospital Res Inst
2024–2029
Pharmacometric Approaches to Precision Optimization of Ivacaftor Response in Cystic Fibrosis Patients
National Heart, Lung, and Blood Institute · K23
Contact PI · $838.6K · Arkansas Children's Hospital Res Inst
2020–2025
Effects of Ozone on CFTR Expression and HIF Signaling
National Institute of Environmental Health Sciences · F30
Contact PI · $96.8K · University of Alabama at Birmingham
2006–2009

Clinical trials

Ensuring Access to Optimal Therapy in CF: The ENACT Study
Principal investigator · Recruiting · Phase 4
Arkansas Children's Hospital Research Institute
2025–2030